Study: Breast cancer screening does save lives

September 6, 2012

(Medical Xpress)—Women who undergo screening halve their risk of dying from breast cancer, a new study from the University of Melbourne has found. The study, published today in Cancer Epidemiology, Biomarkers and Prevention is the largest of its kind in Australia and one of the largest in the world. It followed about 4,000 women in a study of the BreastScreen program in Western Australia.

University of Melbourne Research Fellow Dr Carolyn Nickson and colleagues from the Melbourne School of said the findings reaffirmed the importance and efficacy of mammography.

The study focused on aged 50-69 years, who are in the target age range for screening. It included 427 cases where women had died from and 3,650 control women who were still alive when the other women died.

The research team compared screening attendance between the two groups and found screening was much lower among women who had died from breast cancer, a finding that is consistent with a similar study from South Australia and with numerous studies from around the world. Comparison with similar studies showed an average estimate of a 49% reduced risk of dying.

Some other studies including studies from Australia claim that screening doesn't reduce risk of dying from breast cancer. However, these studies do not compare outcomes for individual women.

"Sound research methods have been used in this study. I believe it is time to move on from the debate about whether reduces mortality and to instead direct research resources to help improve the program for women who choose to use it," Dr Nickson said.

"It is important that Australian women have accurate information about the pros and cons of participating in BreastScreen. The findings of this study may help women decide whether to participate."

"Early detection is the key to early treatment and the free BreastScreen program is the best health service available to detect breast cancers earlier in women aged 50-69 years."

Explore further: Mammography screening reduced risk for death from breast cancer by half

Related Stories

Mammography screening reduced risk for death from breast cancer by half

December 6, 2011
A new case-control study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, shows that women who participated in at least three screening mammograms had a ...

BreastScreen: balancing benefits and harms

November 4, 2011
New research has questioned the relative impact of mammographic screening in reducing deaths from breast cancer, concluding that it is not responsible for most of the recent reduction in mortality rates and may in fact cause ...

Heart disease beats breast cancer as the biggest killer

June 19, 2011
Breast cancer accounts for almost a third of all cancer cases reported in women. However advances in the treatment for breast cancer, and early detection, have improved the chances of survival from the disease. New research ...

Large breasts a cancer risk: study

July 25, 2012
(Medical Xpress) -- Women with large breasts have a higher incidence of breast cancer than those with average-sized breasts, according to a study by medical students and researchers at The University of Western Australia ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.